Kidney cancer
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
I'll help you understand kidney cancer (also called renal cell carcinoma or RCC) using trusted medical sources.
According to the National Cancer Institute (NCI), kidney cancer most commonly starts in the lining of tiny tubes within the kidneys. The most common type is called renal cell carcinoma (RCC), which accounts for about 90% of kidney cancers.
Key facts from the American Cancer Society (ACS):
- Main risk factors include: • Smoking • Obesity • High blood pressure • Family history • Advanced kidney disease • Certain inherited conditions
The National Comprehensive Cancer Network (NCCN) Guidelines outline the main treatment options:
- Surgery (partial or complete kidney removal)
- Targeted therapy drugs
- Immunotherapy
- Active surveillance for small tumors
- Ablation procedures for small tumors
According to ASCO (American Society of Clinical Oncology) Guidelines, treatment choices depend on several factors:
- Stage of the cancer
- Location and size of the tumor
- Overall health status
- Patient preferences
- Specific type of kidney cancer
It's important to note that kidney cancer treatment has advanced significantly in recent years. The FDA has approved several new targeted therapies and immunotherapy combinations that have improved outcomes for many patients.
Always remember that this information is general - your specific treatment plan should be discussed with your healthcare team, as they understand your individual case best.
Would you like me to explain more about any particular aspect of kidney cancer, such as diagnosis, staging, or specific treatments?
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ